Clinical trial
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
NCT00884052 is registered in ClinicalTrials.gov with Richard H. Haas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
- Lead sponsor
- Richard H. Haas
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- October 31, 2011
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disorder of fetus or newborn, seizures